8-K current report · filed Nov 6, 2026

U S PHYSICAL THERAPY INC /NV (USPH) 8-K Current Report: November 6, 2026

Item 2.02Item 8.01Item EX-99.1USPH overview

Short answer

U S PHYSICAL THERAPY INC /NV (USPH) filed an 8-K current report with the SEC on November 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Q3 and nine-month 2026 operating results reported for periods ended September 30, 2026.

U S PHYSICAL THERAPY INC /NV 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 and nine-month 2026 operating results reported for periods ended September 30, 2026
  • Results cover outpatient physical therapy clinics and industrial injury prevention services
  • Detailed financial figures and management commentary available in Exhibit 99.1 press release

Item 8.01 · Other Events

  • Quarterly dividend declared at $0.46 per share
  • Payment date December 11, 2026, for shareholders of record November 16, 2026
  • Dividend declaration signals continued shareholder-return commitment and requires cash funding

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $223M, up 13%, with visits up 8% and revenue per visit rising to $111
  • Adjusted EBITDA $28M, up from $24M, while GAAP EPS fell to $(1.04) from $0.48 due largely to earn-out valuation effects
  • Hospital-affiliated clinics generated $25M revenue, supporting EBITDA growth after all 72 acquired clinics were integrated
  • Debt rose to $247M from $162M, increasing leverage; $171M interest-rate swap fixes term debt at 4.6% from June 30, 2027 through April 14, 2031
  • 2026 adjusted EBITDA guidance reaffirmed at $102M-$106M; quarterly dividend increased to $0.46 payable December 11, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other U S PHYSICAL THERAPY INC /NV 8-K filings

Get the next USPH 8-K as it lands

Follow USPH for push alerts, or ask the research agent what this filing means.